In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis
1989 ◽
Vol 23
(1)
◽
pp. 11-18
◽
2002 ◽
Vol 76
(24)
◽
pp. 13106-13110
◽
Keyword(s):
1994 ◽
Vol 53
(1)
◽
pp. 101-107
◽
1992 ◽
Vol 36
(2-3)
◽
pp. 105-115
◽
1988 ◽
Vol 111
(2)
◽
pp. 219-226
◽